S&P 500
(-0.01%) 5 468.54 points
Dow Jones
(0.10%) 39 152 points
Nasdaq
(0.25%) 17 761 points
Oil
(0.09%) $80.90
Gas
(-5.04%) $2.62
Gold
(-0.80%) $2 312.10
Silver
(-0.11%) $28.84
Platinum
(3.25%) $1 018.50
USD/EUR
(0.34%) $0.936
USD/NOK
(0.76%) $10.68
USD/GBP
(0.50%) $0.792
USD/RUB
(-0.28%) $87.25

Realaus laiko atnaujinimai Nephros Inc [NEPH]

Birža: NASDAQ Sektorius: Healthcare Pramonė: Medical Instruments & Supplies
Atnaujinta26 birž. 2024 @ 21:45

-0.48% $ 2.08

Live Chart Being Loaded With Signals

Commentary (26 birž. 2024 @ 21:45):
Our systems believe the stock currently is undervalued by 0.01% compare to its pairs and should correct upwards.
Profile picture for Nephros Inc

Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products...

Stats
Šios dienos apimtis 3 886
Vidutinė apimtis 14 579
Rinkos kapitalizacija 21.93M
EPS $-0.0161 ( Q1 | 2024-05-09 )
Kita pelno data ( $-0.0100 ) 2024-08-07
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -14.86
(Sector) 42.63
(Industry) 0
ATR14 $0 (0.00%)
AKYA 5.52%
ANGO 1.50%
APR 0.00%
ATRC 6.30%
ATRI 0.15%
ATRS 0.18%
AVGR 0.00%
AZTA 0.25%
BLFS -0.14%
EKSO 1.98%
FEMY -2.73%
GMVD 1.38%
HBIO 0.34%
HOLX 0.53%
ICUI 1.32%
IIN 0.12%
ISRG -0.02%
KRMD -2.68%
LMAT 0.14%
LMNX 0.00%
MASI -1.56%
MBOT -1.51%
MHUA 2.86%
MMSI 0.09%
NEPH -0.48%
NSTG -37.43%
NVCR 1.00%
NXGL -4.63%
OSUR -1.18%
PDEX 0.13%
PLSE -0.80%
POAI -1.89%
QDEL 0.43%
RGEN 2.98%
SDC -53.45%
SMTI -0.89%
STAA 6.40%
STSS -2.51%
UTMD 0.37%
XRAY 0.40%
ZTEK 3.41%
Insider Trading
Date Person Action Amount type
2024-05-30 Amron Arthur H Buy 3 000 Common Stock
2024-05-28 Amron Arthur H Buy 2 000 Common Stock
2024-05-16 Banks Robert R. Jr. Buy 50 000 Common Stock
2024-05-14 Banks Robert R. Jr. Buy 10 406 Stock Option (right to buy)
2024-05-14 Amron Arthur H Buy 7 323 Stock Option (Right to Buy)
INSIDER POWER
19.09
Last 97 transactions
Buy: 1 543 813 | Sell: 673 582
Koreliacija (AI algo v.1.1b): Undervalued: 0.01% $2.08 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Nephros Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
TTEC0.961
TWKS0.959
SMSI0.958
UONEK0.956
XMTR0.952
CLEU0.951
HRZN0.951
UONE0.951
RETO0.946
EEIQ0.945
10 Labiausiai neigiamai susiję koreliacijos
EBAY-0.962
MNMD-0.961
ROOT-0.958
RNA-0.958
IINN-0.953
PUBM-0.95
CRAI-0.949
NTRA-0.949
PPC-0.947
LFMDP-0.942

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Nephros Inc Finansinės ataskaitos

Annual 2023
Pajamos: $14.24M
Bruto pelnas: $8.19M (57.53 %)
EPS: $-0.150
FY 2023
Pajamos: $14.24M
Bruto pelnas: $8.19M (57.53 %)
EPS: $-0.150
FY 2022
Pajamos: $9.98M
Bruto pelnas: $4.73M (47.43 %)
EPS: $-0.710
FY 2021
Pajamos: $10.40M
Bruto pelnas: $5.74M (55.20 %)
EPS: $-0.385

Financial Reports:

No articles found.

Nephros Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Nephros Inc

Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells real-time water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it offers water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and AETHER brands for the food service, hospitality, convenience store, and health care markets. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.

Total Execution Time: 1.3045580387115 seconds
Number of API calls: 3
Number of DB calls: 9